Patent · US Active

Methods of treating metabolic disorders

US9598477B2 · kind B2 · utility

0Cited by
1References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 9, 2013
Grant dateMar 21, 2017
Priority date
Expiry dateAug 9, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention addresses the problem of providing a means which is effective for the induction of the differentiation of a brown adipocyte and therefore enables a brown adipocyte to be used for and applied to, for example, the prevention/treatment of obesity or metabolic syndrome. Provided is a brown adipocyte differentiation-inducing agent containing, as an active ingredient, (1) CREG1 protein or (2) an expression vector carrying CREG1 gene.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.